118 related articles for article (PubMed ID: 6174468)
21. In vitro effects of two immunopotentiators, Isoprinosine and NPT 15392, on murine T-cell differentiation and function.
Ikehara S; Hadden JW; Good RA; Lunzer DG; Pahwa RN
Thymus; 1981 Aug; 3(2):87-95. PubMed ID: 6170135
[TBL] [Abstract][Full Text] [Related]
22. The effect of isoprinosine on the PHA response of monocyte-depleted and undepleted peripheral blood mononuclear cells.
Jacobsen PL; Greenspan JS
J Immunopharmacol; 1982-1983; 4(4):355-65. PubMed ID: 6192176
[TBL] [Abstract][Full Text] [Related]
23. Immunorestoration in children with recurrent respiratory infections treated with isoprinosine.
Wiedermann D; Wiedermannová D; Lokaj J
Int J Immunopharmacol; 1987; 9(8):947-9. PubMed ID: 2448256
[TBL] [Abstract][Full Text] [Related]
24. Isoprinosine enhances the activation of sensitized lymphocytes by Epstein-Barr virus antigens.
Sundar SK; Barile G; Menezes J
Int J Immunopharmacol; 1985; 7(2):187-92. PubMed ID: 2409036
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic immunoenhancement in the elderly: in vitro effects of isoprinosine.
Delafuente JC; Panush RS
Clin Immunol Immunopathol; 1988 Jun; 47(3):363-7. PubMed ID: 2453315
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.
Nakamura T; Miyasaka N; Pope RM; Talal N; Russell IJ
Clin Exp Immunol; 1983 Apr; 52(1):67-74. PubMed ID: 6190598
[TBL] [Abstract][Full Text] [Related]
27. [Effect of zoledronate on the cytotoxicity of γδ T cells from PBMCs of osteosarcoma patients against osteosarcoma].
Li Z; Tang J; Sun L; Ye Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jan; 29(1):6-9. PubMed ID: 23294710
[TBL] [Abstract][Full Text] [Related]
28. Immunopotentiation of impaired lymphocyte functions in vitro by isoprinosine in prodromal subjects and AIDS patients.
Tsang P; Lew F; O'Brien G; Selikoff IJ; Bekesi JG
Int J Immunopharmacol; 1985; 7(4):511-4. PubMed ID: 2412972
[TBL] [Abstract][Full Text] [Related]
29. Preliminary characterization in mice of the effect of isoprinosine on the immune system.
Vecchi A; Sironi M; Spreafico F
Cancer Treat Rep; 1978 Nov; 62(11):1975-9. PubMed ID: 83191
[TBL] [Abstract][Full Text] [Related]
30. An open-label trial of immunomodulation therapy with inosiplex (Isoprinosine) in patients with alopecia totalis and cell-mediated immunodeficiency.
Galbraith GM; Thiers BH; Fudenberg HH
J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):224-30. PubMed ID: 6207216
[TBL] [Abstract][Full Text] [Related]
31. An animal model for evaluation of antigen-specific dialyzable leukocyte extracts therapy of osteosarcoma.
Tsang KY; Pan JF; Fudenberg HH
Clin Immunol Immunopathol; 1987 Mar; 42(3):360-9. PubMed ID: 3470162
[TBL] [Abstract][Full Text] [Related]
32. Isoprinosine-induced modulation of T-helper-cell subsets and antigen-presenting monocytes (Leu M3 + Ia +) resulted in improvement of T- and B-lymphocyte functions, in vitro in ARC and AIDS patients.
Tsang PH; Sei Y; Bekesi JG
Clin Immunol Immunopathol; 1987 Nov; 45(2):166-76. PubMed ID: 2444374
[TBL] [Abstract][Full Text] [Related]
33. [Action of isoprinosine on the "in vitro" activation of human lymphocytes (author's transl)].
Morin A; Griscelli C; Daguillard F
Ann Immunol (Paris); 1979; 130C(4):541-51. PubMed ID: 91345
[TBL] [Abstract][Full Text] [Related]
34. Effects of isoprinosine in animal models of depressed T-cell function.
Binderup L
Int J Immunopharmacol; 1985; 7(1):93-101. PubMed ID: 2581907
[TBL] [Abstract][Full Text] [Related]
35. Study of the antiallergic component of inosine pranobex (Inosiplex, Isoprinosine).
Schmutzler W; Neukirch B; Ziesche R
Int Arch Allergy Appl Immunol; 1989; 88(1-2):244-6. PubMed ID: 2468618
[TBL] [Abstract][Full Text] [Related]
36. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS.
Bekesi JG; Tsang PH; Wallace JI; Roboz JP
J Clin Lab Immunol; 1987 Dec; 24(4):155-61. PubMed ID: 2452254
[TBL] [Abstract][Full Text] [Related]
37. Isoprinosine effects on interleukin-1 production in acquired immune deficiency syndrome (AIDS).
Tsang KY; Donnelly RP; Galbraith GM; Fudenberg HH
Int J Immunopharmacol; 1986; 8(4):437-41. PubMed ID: 2427461
[TBL] [Abstract][Full Text] [Related]
38. Restoration of impaired B- and T-lymphocyte subsets and functions in vitro by isoprinosine in prodromal homosexuals and AIDS patients.
Tsang PH; Zanjani MD; Warner N; Bekesi JG
J Clin Lab Immunol; 1986 Aug; 20(4):159-65. PubMed ID: 2428980
[TBL] [Abstract][Full Text] [Related]
39. Effect of isoprinosine on sialylation of interleukin-2.
Tsang KY; Boutin B; Pathak SK; Donnelly R; Koopmann WR; Fleck R; Miribel L; Arnaud P
Immunol Lett; 1986 Apr; 12(4):195-200. PubMed ID: 2424829
[TBL] [Abstract][Full Text] [Related]
40. Isoprinosine stimulates granulocyte chemiluminescence and inhibits monocyte chemiluminescence in vitro.
Flø RW; Naess A; Albrektsen G; Solberg CO
APMIS; 1994 Apr; 102(4):249-54. PubMed ID: 7516672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
